Mdacc
Hematology
Dr. Simrit Parmar, MD
|
|
Give Review
Dr. Simrit Parmar practices Hematology. She went to Dayanand Medical College . Simrit Parmar is a published doctor. She has 63 papers published. The most current publication "Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia." Simrit Parmar is registered with Medicare and accepts Medicare payments.
Publications
- Autologous hematopoietic stem Cell transplantation in light chain amyloidosis (AL) with renal involvement.
- Treg adoptive therapy: is more better?
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
- High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
- Enforced fucosylation of cord blood hematopoietic Cells accelerates neutrophil and platelet engraftment after transplantation.
- Clonal evolution of Acute myeloid leukemia relapsed after 19 years of remission.
- General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.
- Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem Cell transplantation for relapsed myeloma.
- Ex vivo fucosylation of 3rd party human regulatory T Cells enhances anti-graft versus host disease potency in vivo.
- Regulatory B Cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
- Short-term cardiac toxicity of autologous hematopoietic stem Cell transplant for multiple myeloma.
- Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
- Is there an expiration date for a cord blood unit in storage?
- FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T Cells.
- Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic Cell transplantation in patients with multiple myeloma.
- Third-party umbilical cord blood-derived regulatory T Cells prevent xenogenic graft-versus-host disease.
- Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in Myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
- Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood enGraftment.
- Impact of t(11;14)(q13;q32) on the Outcome of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients w...
- Randomized, dose-escalation study of the p38? MAPK inhibitor SCIO-469 in patients with Myelodysplastic syndrome.
- Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Cord-blood engraftment with ex vivo mesenchymal-Cell coculture.
- Dose intensification of Busulfan in the preparative regimen is associated with improved survival: A Phase I/II Controlled, Randomized Study.
- Allogeneic hematopoietic stem Cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Antigen presenting Cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer Cells with anti-myeloma activity.
- Pathogenesis of increased risk of Thrombosis in cancer.
- Jak family of kinases in Cancer.
- Acute promyelocytic leukaemia:a review.
- Activation of protein kinase C delta by all-trans-retinoic acid.
- Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
- Predictors of prolonged survival after allogeneic hematopoietic stem Cell transplantation for multiple myeloma.
- Hematopoietic stem Cell transplantation for myelodysplastic syndrome: a review.
- Feasibility of autologous hematopoietic stem Cell transplant in patients aged â¥70 years with multiple myeloma.
- Ex vivo graft purging and expansion of autologous blood progenitor Cell products from patients with Multiple Myeloma.
- Aberrant epigenetic and genetic marks are seen in Myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.
- Umbilical cord blood transplantation.
- Novel transplant strategies for generating graft-versus-leukemia effect in Acute myeloid leukemia.
- Prophylaxis of Graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively ra...
- Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-Cell collection.
- Overcoming the barriers to umbilical cord blood transplantation.
- Hematopoietic stem Cell transplantation for myelodysplastic syndrome.
- Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib.
- Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of Acute graft-versus-host disease.
- Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
- Inhibition of overactivated p38 MAPK can restore hematopoiesis in Myelodysplastic syndrome progenitors.
- Implications of therapy choice on overall survival in metastatic renal Cell carcinoma: a single institution experience.
- Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in Myelodysplastic syndromes.
- Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous Leukemia cells.
- Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous Leukemia cells.
- Signalling pathways activated by all-trans-retinoic acid in Acute promyelocytic leukemia cells.
- Activation of the p70 S6 kinase by all-trans-retinoic acid in Acute promyelocytic leukemia cells.
- Phase II trial of arsenic trioxide in relapsed and refractory Acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old.
- Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing Cells.
- Right atrial and ventricular thrombus infiltrated with osteoblastic osteosarcoma.
- Interferons: mechanisms of action and clinical applications.
Schools
Dayanand Medical College Baba Farid University Of Health Sciences
Nw Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
McGaw Medical Center of Northwestern University -
Dayanand Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1629047113 | |
| NPPES Provider LastName | PARMAR | |
| NPPES Provider FirstName | SIMRIT | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 210.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629047113 |
| Last Name Of The Provider | PARMAR |
| First Name Of The Provider | SIMRIT |
| View All |
Similar Doctors
|
|
Dr. Jennifer Atlas, MD |
|
Dr. Krishna K. Pachipala, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monisha Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Thachil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl F. Hirsch-Ginsberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Razelle Kurzrock, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Luis E. Fayad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stefan O. Ciurea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gauri R. Varadhachary, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Amin M. Alousi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joseph D. Khoury, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nina Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sik Choo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chitra Balasundaram, MD |
|
|
Dr. John V. Heymach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jeffrey J. Molldrem, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Emrullah Yilmaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marguerite M. Rosales, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zahida Yasin, MD
This Doctor is OpenDoctor Recommended.
|